Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-randomized, Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients With Reduced Ejection Fraction or in Heart Failure Patients With Preserved Ejection Fraction

NCT03030274 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.

NCT NCT03030274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03030274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-randomized, Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients With Reduced Ejection Fraction or in Heart Failure Patients With Preserved Ejection Fraction
Lead sponsor
Occlutech International AB
Phase
Not applicable
Overall status
Completed
Start date
October 11, 2017
Completion date
March 2, 2022
Enrollment
106 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure low output